Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kura Oncology (KURA) EPS (Weighted Average and Diluted) (2024 - 2025)

Historic EPS (Weighted Average and Diluted) for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to -$0.85.

  • Kura Oncology's EPS (Weighted Average and Diluted) fell 3492.06% to -$0.85 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.48, marking a year-over-year change of. This contributed to the annual value of -$2.02 for FY2024, which is 291.93% up from last year.
  • According to the latest figures from Q3 2025, Kura Oncology's EPS (Weighted Average and Diluted) is -$0.85, which was down 3492.06% from -$0.75 recorded in Q2 2025.
  • Kura Oncology's EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.2 during Q4 2024, with a 5-year trough of -$0.85 in Q3 2025.